to the AGE-binding proteins, F(ab')2 fragments of these antibodies and by soluble RAGE. When MP migration in response to N-formyl-Met-Leu-Phe was studied in a chemotaxis chamber with AGE-albumin adsorbed to the upper surface of the chamber membrane, movement of MPs to the lower compartment was decreased because of interaction of the glycated proteins with RAGE and LF-L on the cell surface. The capacity of AGEs to attract and retain MPs was shown by implanting polytetrafluoroethylene (PTFE) mesh impregnated with AGEalbumin into rats: within 4 d a florid mononuclear cell infiltrate was evident in contrast to the lack of a significant cellular response to PTFE with adsorbed native albumin. These data indicate that RAGE and LF-L have a central role in the interaction of AGEs with human mononuclear cells and that AGEs can serve as a nidus to attract MPs in vivo. (J. Clin. Invest. 1993. 91:2155-2168
Introduction
The extended interaction of proteins with aldose sugars, such as glucose or ribose ( 1-3), leads to the formation of advanced glycation end products of proteins (AGEs).' AGEs bind to Receivedfor publication 28 April 1992 and in revisedform 4 November 1992.
1. Abbreviations used in this paper: AGE, advanced glycation end product; EBSS, Earle's balanced salt solution; EC, endothelial cell; LF-L, lactoferrin-like; MP, mononuclear phagocyte; PTFE, polytetrafluoroethylene; RAGE, receptor for AGE; sRAGE, soluble RAGE. endothelial cells (ECs) and mononuclear phagocytes (MPs) and alter cellular functions. Exposure of cultured ECs to AGEs perturbs barrier and coagulant function of the cell monolayer and stimulates cell growth (4, 5) . MP-AGE interaction leads to cell activation, as evidenced by the induction of MP migration, as well as release of cytokines and platelet-derived growth factor (6, 7) .
The accumulation of AGEs in the vessel wall, especially in diabetes, where their capacity to perturb endothelial and MP functions may contribute to the development of vascular lesions, has prompted several investigators to study interactions of AGEs with macrophages and endothelial cells (8) (9) (10) (11) (12) . Radoff et al. (9) and Yang et al. ( 1) identified two cell surface proteins on rodent macrophages that may be involved in the cellular interaction with AGEs: a 90-kD polypeptide that interacts with furanyl-furoyl-imidazole (a synthetic compound possibly related to AGEs) (9) and a 60-kD polypeptide that reacts directly with AGE-albumin ( 11) . We have isolated and characterized two polypeptides from extracts of bovine lung on the basis of their ability to bind AGEs: a protein that is a new member of the immunoglobulin superfamily of receptors (termed receptor for AGEs or RAGE) and a lactoferrin-like (LF-L) AGE-binding protein (8, 10) . RAGE and the LF-L polypeptide are both present on the surface ofbovine ECs, and specific antibodies to each ofthese polypeptides block the binding of '251-AGE-albumin to ECs (10) .
In this study, we have identified RAGE and the LF-L AGE-binding protein in human MPs and have demonstrated that these polypeptides mediate the binding and endocytosis of '251-AGE-albumin by MPs. Whereas engagement ofthese polypeptides by soluble AGE-albumin induces MP chemotaxis, interaction of these MP cell surface receptors with immobilized AGEs slows their migration. These results demonstrate that RAGE and the LF-L AGE binding protein have a central role in mediating the effects ofAGEs on MPs and suggest that soluble AGEs could attract MPs into vessel walls and tissues, where deposits of immobilized AGEs could lead to their retention. This work outlines a possible mechanism, in addition to the formation of oxidized lipoproteins ( 13) , through which modified proteins can draw monocytes into the vessel wall.
Methods
Preparation ofhuman MPs. Human peripheral blood monocytes were isolated from the blood of normal healthy volunteers ( 13 ) . Blood was centrifuged on Histopaque 1077 (Sigma Chemical Co., St. Louis, MO), the mononuclear cell fraction was obtained, washed twice in Earle's balanced salt solution (EBSS), resuspended in RPMI 1640 containing human serum (10%; Gemini, Calabasas, CA), plated on 100-mm tissue culture dishes, and incubated at 37°C for 1-2 h. Nonadherent cells were removed by washing the plate twice with EBSS and adherent cells were harvested by incubation with calcium-magnesiumfree EBSS containing EDTA (2 mM) for 15 min at 370C followed by extensive washing in EBSS and resuspension in RPMI 1640 containing human serum (10%) at a concentration of 106 cells/ml (10) .
Preparation ofglycatedproteins in vitro, AGE-bindingproteins, and antibodies. AGE albumin was prepared by incubating bovine serum albumin (fraction V; Sigma Chemical Co.) with either glucose-6-phosphate (250 mM; Sigma Chemical Co.), glucose (0.5 M; Sigma Chemical Co.), or ribose (250 mM; Sigma Chemical Co.) at 370C for 6-8 wk. Glycated proteins were characterized by their identical binding properties to ECs and purified AGE-binding proteins, as reported previously (5, 10) , and by their fluorescence (1) . Isoelectric focusing demonstrated that the pIs were very similar for AGE-albumin prepared in the presence of either glucose, ribose, or glucose-6-phosphate (pI 4.55) (the pl of native albumin was 4.7-4.9), and SDS-PAGE showed a single major band. Collagen I (Collaborative Research, Bedford, MA) was glycated using the same procedure. Controls consisted ofthe same initial preparations of albumin and collagen I incubated at 370C in an identical fashion, except that aldoses were omitted from the reaction mixture. Radiolabeling of albumin/AGE-albumin was accomplished bythe lactoperoxidase method using Enzymobeads (Bio-Rad Laboratories, Richmond, CA), and the final specific radioactivity of the tracers was 1.5 X 103 cpm/ng (10) .
AGE-binding proteins were purified to homogeneity from a detergent extract of bovine lung acetone powder ( 10) . RAGE migrated as a single band on reduced and nonreduced SDS-PAGE with a relative molecular mass of 35 kD. This form of RAGE has been termed soluble RAGE (sRAGE), as it probably represents the amino terminal two thirds of the molecule (8) . Before use in chemotaxis assays, sRAGE was dialyzed versus PBS containing octyl-fl-glucoside (0.01%).
Purified LF-L AGE-binding protein also migrated as a single band on SDS-PAGE with a relative molecular mass of 80 kD (10) . Antibodies prepared to each ofthe AGE-binding proteins in rabbits and guinea pigs have been shown to be monospecific, on the basis of Western blotting studies in which antibody staining of a single protein in EC (10) or partially purified lung (data not shown) extracts could be blocked by addition of the respective, purified, soluble AGE-binding protein. Antisera were chromatographed on protein A-agarose to purify the IgG fraction. In addition, for the LF-L AGE-binding protein, antibody was affinity purified on a lactoferrin-affi-gel 10 column. Lactoferrin (100 mg; Sigma Chemical Co.) was bound to affi-gel 10 (25 ml; Bio-Rad Laboratories, Sacramento, CA) according to the manufacturer's instructions (coupling efficiency 90%). Anti-LF-L serum (5 ml) was applied to the lactoferrin-affi-gel 10 (25 ml), and after extensive washing the adsorbed immunoglobulins were eluted with glycine buffer (0.2 M; pH 2.5). The F(ab')2 fragments of the immune IgG raised to RAGE and LF-L AGE-binding protein were prepared by pepsin digestion of IgG fractions for 6 h at 37°C (5 ytg pepsin/mg ofIgG in 100 mM sodium citrate buffer). The reaction was stopped by the addition of I / 10 vol ofTris ( 3 M; pH 8.8), followed by centrifugation at 10,000 gfor 30 min, and the digest was dialyzed against PBS. F(ab')2 fragments were separated from other components ofthe reaction mixture using a protein A-Sepharose CL-4B (Pharmacia Inc., Piscataway, NJ) column. The pass-through was collected, and the purity of the F(ab')2-containing fractions was determined by SDS-PAGE. To test the effect of intact antibodies or their F(ab')2 fragments in chemotaxis assays, suspensions of monocytes ( 106/ml) were preincubated for 1 h in RPMI 1640 containing fetal bovine serum (1%) and the indicated immune IgG, F(ab')2 or nonimmune guinea pig IgG at 40C. Cells were then washed twice in EBSS and resuspended in RPMI 1640 containing fetal bovine serum (1%) at a concentration of 2 X I05 cells/ml for chemotaxis assays.
Antibodies to AGE-moieties on proteins were prepared by immunizing guinea pigs with AGE-albumin or AGE-keyhole limpet hemocyanin and affinity purifying the antibody population that selectively recognized AGEs (not the native protein backbone) through sequential chromatography on columns with immobilized native protein and then AGE-moiety. (Yan, S. D., A. M. Schmidt, J. Brett, and D. Stern, manuscript is in preparation concerning the characterization of the anti-AGE antibodies) This population of antibodies was used to develop an ELISA assay for AGEs. In brief, ELISA wells were coated with a range of concentrations of AGE albumin (0.025-250 ,g per well)
overnight at 40C in carbonate buffer (pH 9). Wells were washed three times (0.1 ml per wash) with Dulbecco's PBS containing Tween 20 (0.05%), excess sites in the well were blocked by incubation with goat serum ( 1%) in PBS for 2 h at 370C, and then wells were washed again as above. A range of dilutions of patient plasma, either that derived from healthy volunteers (< 41 yr) or individuals with diabetes, was added to wells along with a standard concentration of antibody ( 1:1,600 dilution) for 2 h at 370C. Wells were then washed, secondary antibody was added, peroxidase-conjugated goat anti-guinea pig IgG (Sigma Chemical Co.), for I h at 370C and O-phenylenediamine (Sigma Chemical Co.) was used to visualize bound antibody. The reaction was stopped with sulfuric acid and OD495 was determined. This ELISA was used to select diabetic plasma from which AGEs were isolated as described below. By immunofluorescence, anti-AGE antibodies did not specifically stain human MPs.
The anti-AGE antibody was also coupled to affi-gel 10 according to the manufacturer's instructions, and then the resin was incubated with plasma from diabetics (plasma of two patients with diabetes, which contained AGEs by ELISA, was pooled) or normal patients (plasma of two individuals that were negative for AGEs) for 2 h at 370C (20 ml of plasma/ 10 ml of resin). The resin was washed extensively with Tris (20 mM; pH 7.4)-buffered saline (0.1 M). Material bound to the resin was eluted with a high salt (NaCl, 1 M) wash, and the eluate was dialyzed versus Tris-buffered saline. The latter material was concentrated using Centricon tubes (MWCO 10,000; Amicon, Beverly, MA), and protein concentration was determined by standard protein assay (Bio-Rad). Negligible protein was detectable in the eluate from the column to which normal plasma had been applied, so that similar volumes of column eluate were processed in a manner identical to that for samples from diabetic plasma. This material was used in chemotaxis assays with MPs as described below.
Western blotting. For samples blotted with anti-RAGE IgG, human MPs ( 108 cells) prepared as described above were solubilized in Tris (20 mM; pH 7.4), NaCI (0.1 M), octyl-,3-glucoside (1%), and PMSF (1 mM), and chromatographed on hydroxylapatite (10 ml; IBF Biotechnics, Columbia, MD). The resin was washed extensively with Trisbuffered saline (Tris, 20 mM, pH 7.4; NaCl, 0.1 M) containing octyl-,Bglucoside (0.1%) and eluted in the same buffer with the final NaCI concentration adjusted to 1 M. For samples to be analyzed with anti-LF-L IgG, the cell pellet was solubilized directly in SDS-PAGE sample buffer without reducing agent ( 16) . In both cases the cell extracts were then applied to SDS-PAGE (10%) and subjected to Western blotting by the Blotto procedure ( 17 ) except that membranes containing LF-L AGE-binding protein were blocked with albumin solution (5%) rather than nonfat dry milk. After reaction with primary antibody (anti-RAGE IgG or anti-LF-L IgG), sites of IgG binding were visualized by chemiluminescence using peroxidase-conjugated secondary antibody (Amersham Corp., Arlington Heights, IL) or using the same antibody developed with 3,3'-diaminobenzidine tetrahydrochloride (Sigma Chemical Co.).
To prove that the two AGE-binding proteins were distinct and not common subunits of a single receptor, detergent extracts from MPs ( 108 cells, prepared as described above) were chromatographed on im-munoaffinity columns with immobilized anti-RAGE IgG or anti-LF-L IgG. The latter columns were prepared by coupling 15 mg of either anti-RAGE IgG or anti-LF-L IgG to affi-gel 10. In each case, MP detergent extract (5 ml) was incubated with anti-RAGE IgG-affi-gel or anti-LF-L IgG-affi-gel (5 ml in each case) overnight at 4VC. The passthrough was collected, the resin was then washed extensively in Trisbuffered saline containing octyl-#-glucoside (0.1%), and the column was eluted with either NaCI ( 1 M) (anti-RAGE IgG-affi-gel) or glycine (0.2 M, pH 2.5) (anti-LF-L IgG-affi-gel) (although similar results were obtained when the anti-RAGE IgG-affi-gel was eluted with acidic glycine buffer, since elution of RAGE was complete in high salt buffer, the latter approach was used to enhance stability of the immobilized antibodies, which appeared to deteriorate more rapidly with multiple exposures to acidic conditions). The pass-through and eluted fractions from each column were dialyzed overnight versus Tris-buffered saline containing octyl-f3-glucoside (0.1%). Fractions were then subjected to SDS-PAGE (10%) followed by Western blotting with anti-RAGE IgG and anti-LF-L IgG as above.
Immunofluorescence. Mononuclear cells, isolated as described above, were allowed to adhere to 12- 4°C . Binding of'251I-AGE-albumin was terminated by washing cultures five times with cold HBSS, and cell-bound material was eluted during a 5-min incubation at 37°C with buffer-containing heparin (1 mg/ml) (5, 10) . For assays employing antibodies, IgGs at the indicated dilutions were preincubated with MPs in binding buffer at 4°C for 2 h, cells were washed in HBSS, and then experiments were performed as above. Results ofbinding studies represent the mean±SE ofat least quadruplicate determinations. Equilibrium binding data were analyzed by the equation ofKlotz and Hunston ( 18) using nonlinear least-squares analysis (Enzfitter), as described previously (10) .
Cell-associated radioligand was divided into cell surface-bound and internalized pools on the basis ofthe following elution techniques.
Binding studies were performed by incubating 1251I-AGE albumin with MPs (5 x 104 cells per 96 well) for 3 h at 4°C, washing, and then eluting cell-bound material by 5 min ofexposure ofcells to Tris-buffered saline containing either heparin ( 1 mg/ml), sodium acetate (20 mM; pH 2), dextran sulfate (1 mg/ml), trypsin (0.01 U/ml) or Nonidet P-40 (1%). The amount of cell-associated radioligand eluted by each of these procedures was comparable and was considered to be bound to the cell surface. None of these agents altered cell viability or resulted in detachment of MPs from the plastic surface under these conditions (except for the detergent, which dissolved the cell monolayer). Similar experiments were performed after incubation of '251I-AGE albumin with MPs at 37°C. After elution of cell surface-bound '25I-AGE-albumin with heparin or trypsin, as above, the additional pool ofradioactivity eluted by subsequent incubation with Nonidet P-40 (1%) was considered to be internalized/endocytosed. This was verified morphologically by studies employing AGE-albumin linked to colloidal gold (see below Surface binding and cellular uptake ofAGE-albumin gold conjugates. AGE-albumin (glucose-6-phosphate albumin) colloidal gold conjugates were prepared and used by the general method described previously ( 19, 20) . In brief, suspensions of colloidal gold were prepared (21 ) with an average diameter of 25 nm (22) and conjugated to albumin at pH 6.0. Complete surface labeling was achieved as determined by the serial electrolyte test (23) and labeled colloids were evaluated for stability as previously described (24) . Experiments with goldlabeled AGE-albumin were carried out according to the same general protocols outlined above for radiolabeled AGE-albumin. After binding of gold particles to the surface, unbound particles were removed by washing (in certain cases, bound particles were removed by heparin elution), and samples were prepared for electron microscopy: samples were fixed in 2.5% glutaraldehyde in 0.1 M cacodylate buffer for 30 min, postfixed in 2% osmium tetroxide, dehydrated in ethanol, and embedded in EPON. Sections were viewed in an electron microscope (model 300; Phillips Sci., Mahwah, NJ).
Chemotaxis assays. Chemotaxis assays were performed in 48-well microchemotaxis chambers (Neuro Probe, Bethesda, MD) containing a polycarbonate membrane (5 Am; Nucleopore, Pleasanton, CA). MPs were suspended in RPMI 1640 containing fetal bovine serum (1%), and 104 cells were added per well to the upper chamber. The lower chamber contained the chemotactic stimulus and other agents, as indicated. Assays were performed in triplicate-quadruplicate over a 4-h incubation period at 37°C, after which nonmigrating cells were removed, membranes were fixed in methanol, and migrating cells were visualized with Wright's stain. Cells in nine high-power fields were counted, and the mean and SEM were determined. The results are representative of at least two or more replicate experiments.
Assays with AGEs immobilized on the membrane in the chemotaxis chamber. These experiments were performed according to the general method of Aznavoorian et al. (25) . In brief, before the chemotactic assay, Nucleopore membranes (5 Arm) were floated on a solution of AGE-albumin or control albumin (500 nM) in calcium-magnesium-free Dulbecco's PBS at 37°C overnight and then air dried. In certain experiments an 100-fold molar excess of sRAGE was incubated for 1 h at 37°C with the AGE-albumin or native albumin-coated membranes. The membranes were then washed and MP migration assays were performed with the coated surface of the membrane facing the upper or lower chamber, as indicated.
Phagokinetic track assays. Cell motility on surfaces coated with AGE-albumin or native albumin was assayed by the phagokinetic track technique as described by Albrecht-Buehler (26) . Coverslips were coated with protein by dipping them into solution of AGE-albumin or native albumin (25 mg/ ml in each case; Sigma Chemical Co.), draining the coverslip, exposing it to 100% ethanol, and finally drying it in a stream of hot air. Colloidal gold solution was prepared by mixing 1.8 ml of gold chloride (0.5%; Fischer Scientific, New York), 6 ml of sodium carbonate (36.5 mM), and 11 ml of double-distilled water, boiling, and then adding 1.8 ml of formaldehyde (0.1%). Gold particles formed immediately, as indicated by appearance of a reddish-brown color. Hot gold solution (80-90°C) was added to albumin-coated coverslips in 24-well tissue culture plates, incubated for 45 mm, and then coverslips were washed twice in cell culture medium. For phagokinetic track assays, cells were plated on gold-coated coverslips and incubated 6 h at 370C in a humified atmosphere. At the end of the incubation period, coverslips were fixed in paraformaldehyde (3.5%) in PBS, mounted in PBS-glycerol, and viewed by dark-field microscopy. The same procedure was used to study MP migration on substrates composed of AGE-collagen I and native collagen I.
Implantation ofAGE-derivatized polytetrafluoroethylene (PTFE) tubes into rats. Tubes of PTFE mesh (diameter, 1 cm; length 2 cm; 90-am pore size; Gortex; generously provided by W. L. Gore, Inc., Wakefield, MA) were incubated in solutions containing either AGE-albumin or native albumin (the native albumin had been incubated [6] [7] [8] wk at 370C in the absence of glucose), each at a concentration of 500 Mg/ml, for (8) .
In addition to RAGE, our previous study also identified an LF-L AGE-binding protein in bovine lung extracts that bound AGEs ( 10). This polypeptide was termed the LF-L AGE-binding protein because of identity ofthe amino terminal sequence to lactoferrin, identical mobility on SDS-PAGE, cross-reactivity of the respective antisera, and comparable AGE binding activity of LF-L and lactoferrin. Western blotting of detergent extracts ofMPs with anti-LF-L AGE-binding protein IgG demonstrated a single band with a relative molecular mass of 30 kD ( Fig. 1 B, lane I) . This band migrates more rapidly than the purified bovine LF-L AGE-binding protein isolated from lung, which has a relative molecular mass 80 kD ( Fig. 1 B, lane 2). In contrast, purified RAGE could not be visualized with anti-LF-L IgG (lane 3). Appearance of the bands from MPs and lung (lanes I and 2) was due to the presence of antigenic determinants in LF-L AGE-binding protein from lung, as addition of excess soluble LF-L (the purified 80-kD polypeptide form) prevented visualization of this material (lanes 4 and 5). In contrast, addition of excess RAGE did not diminish the intensity of bands immunoreactive with the anti-LF-L AGEbinding protein antibody (data not shown). The presence of a more rapidly migrating band in extracts ofMPs that reacts with anti-LF-L IgG is consistent with previous observations in which Western blotting of bovine endothelial extracts also showed a more rapidly migrating band with a relative molecular mass 30 kD (10) . Although the mechanism(s) leading to formation ofthis material is at present uncertain, it could arise from proteolytic cleavage of lactoferrin or LF-L (27, 28) .
To establish that RAGE and the 30-kD form of LF-L were distinct molecular entities, detergent extracts of MPs were adsorbed with either affinity-purified anti-LF-L IgG or anti-RAGE IgG coupled to a solid support (Fig. 1 C and D) . When the MP lysate was adsorbed with immobilized anti-RAGE IgG, Western blotting with anti-RAGE IgG revealed (Fig. 1 C) Immunofluorescence studies of nonpermeabilized human MPs to determine if RAGE and LF-L were present on the cell surface (Fig. 2) revealed a diffuse pattern of surface staining with anti-RAGE and anti-LF-L antibody (Fig. 2, B and C, respectively) as compared with nonimmune IgG controls ( Fig.  2A) IgG -4-I-* j1:-l 1:1 10-1 10 to what has been previously reported (29) . The latter experiment used AGE-albumin prepared with glucose-6-phosphate, but similar results were obtained with glycated albumin prepared with glucose or ribose (data not shown). Addition of antibody to RAGE largely blocked the binding of 251I-AGE-albumin to MPs ( Fig. 3 B) ; this was true with 1251-glucose-6-phosphate albumin (Fig. 3 B) , '251I-ribose albumin (Fig. 3 D) , and 1251-glucose albumin (Fig. 3 E) . Inhibition of '251-AGE-albumin binding to MPs was a specific effect ofthe immune IgG, as it was not observed with the same amount of nonimmune IgG or antibody to another MP surface protein, CD4 (Fig. 3, B-E) . High concentrations of antibody were required for effective blocking of'25I-AGE-albumin-monocyte binding, presumably because of immunologic differences between bovine RAGE (to which the antibody was prepared) and human RAGE (with which the antibody is reacting on human MPs). Antibody to the LF-L AGE-binding protein also inhibited the binding of 1251-AGE-albumin to MPs at 4VC (Fig. 3 , C-E) using glycated albumin prepared in the presence of glucose-6-phosphate (Fig. 3 C) , ribose (Fig. 3 D) , or glucose (Fig. 3 E) Time, hr Figure 4 . Cell-associated '25I-AGE-albumin (prepared by incubating albumin with glucose-6-phosphate) is bound to the cell surface at 4VC (A) and internalized 370C (B and C) via interaction with RAGE and LF-L. (A) MPs were incubated with '25I-AGE albumin (100 nM) at 4VC for 3 h, cultures were washed, and cell-associated radioligand was dissociated by exposure to buffer containing heparin, acid, dextran sulfate, trypsin, or detergent (Nonidet P-40), as described in the text. Results shown are the mean±SE of at least quadruplicate determinations. (B) MPs were incubated with '251-AGE albumin ( 100 nM) at 370C for 3 h. After washing, cell-bound '251I-AGE albumin was eluted with buffer containing either heparin or trypsin, followed by detergent, as described in the text. Results shown are the mean±SE of at least quadruplicate determinations. (C) MPs were incubated with 1251-AGE-albumin alone (100 nM; total binding) or in the presence of 20-fold molar excess of unlabeled AGE-albumin (nonspecific binding) for the indicated times at 37"C. As indicated (+Ab), immune IgG to both RAGE and LF-L (final concentration of each, 1.4 and 1.35 mg/ml, respectively) were preincubated with MPs for 1 h at 4VC. Then cultures were washed, and surface-bound radioactivity was eluted with heparin-containing buffer (solid lines), and internalized radioactivity (dashed lines) was determined by subsequent detergent solubilization of the cultures. Data shown represent specific binding (total minus nonspecific binding), the mean of duplicate determinations. Nonimmune IgG at the same concentration as anti-AGE-binding protein IgGs had no effect on '251I-AGE-albumin binding/internalization by MPs in this assay. The experiments were repeated at least two times. tran sulfate, trypsin, or detergent (Fig. 4 A) . At 370C (Fig. 4 B) incubation of MPs with 125I-AGE-albumin also led to the formation of a cell surface-associated pool of cell-bound radioli- gand that could be eluted by exposure of cultures to buffer containing heparin or trypsin treatment. However, at the higher temperature, there was an additional pool of specifically cell-associated radioligand that remained after elution with heparin or trypsin (Fig. 4 B) and was not observed in experiments performed at 40C (at the lower temperature, the pool of 125i-AGE-albumin released from the cell by heparin, trypsin, or detergent coincided exactly). This additional cell-associated 1251-AGE-albumin observed at 370C was released by dissolution of the cells in detergent-containing buffer. Ultrastructural studies with AGE-albumin colloidal gold conjugates confirmed that at 370C a pool of ligand was present on the cell surface (Fig. 5 A) from which it could be eluted with any ofthe treatments described above, as well as a pool of internalized ligand (Fig. 5 B) . The latter was found in membrane-bound vesicles and these internalized AGE-albumin gold conjugates were eluted by dissolution of the cells in detergent (data not shown).
On the basis of this analysis of the localization of cell-associated AGE-albumin, studies were performed to determine if anti-RAGE IgG and anti-LF-L IgG would block binding of 251I-AGE-albumin to MPs at 370C. Preincubation of MPs with simultaneously added anti-RAGE IgG and anti-LF-L IgG at 40C blocked surface binding of 1251I-AGE albumin at 370C (Fig. 4 C) , defined in this experiment as heparin-elutable radioactivity. The presence of antibodies to the AGE-binding proteins also prevented formation ofthe pool ofendocytosed radioactivity (Fig. 4 C) AGEs. When MPs were preincubated with anti-RAGE IgG at 4VC, washed, warmed to 370C, and then placed in the upper compartment of the chemotaxis chamber, the migratory response to glucose-6-phosphate-albumin was blocked in a dosedependent manner (Fig. 7 A) . Migration ofMPs in response to soluble glucose-albumin, ribose-albumin, or patient-derived AGEs was also blocked by anti-RAGE IgG (Fig. 7 , B-D, respectively). F(ab')2 fragments prepared from anti-RAGE IgG had a similar inhibitory effect on MP chemotaxis to AGE-albumin (Fig. 7 A) , though neither anti-RAGE IgG nor the F(ab')2 fragments altered migration in response to FMLP (Fig. 7 A) .
A: Glucose-6phosphate-Albumnn Control experiments with nonimmune IgG and polyclonal IgG to CD4 in place of antibodies to RAGE and LF-L had no effect on MP migration in response to AGE-albumin (Fig. 7, A-D) . These observations suggested that interaction ofAGEs with monocyte RAGE was necessary to initiate chemotaxis in response to soluble AGE-albumin. Supporting this hypothesis, addition of soluble RAGE, which should block interaction of AGEs with their receptors on the surface of MPs, prevented AGE-induced migration (Fig. 8) . For this experiment, excess sRAGE was preincubated with AGE-albumin for 1 h at 370C, the mixture was added to the lower compartment of the chemotaxis chamber, and subsequent migration of MPs in response to soluble AGE-albumin was blocked. In contrast, sRAGE had no effect on the migration of MPs in response to the chemotactic stimulus FMLP (Fig. 8) .
These data, which suggested a role for RAGE in mediating MP migration in response to AGE-albumin, led us to test the effect of preincubation of MPs with anti-LF-L IgG (Fig. 7 , B-D and Fig. 9 ). IgG to the LF-L AGE-binding protein also blocked MP migration to AGE-albumin prepared with glucose-6-phosphate in a dose-dependent manner (Fig. 9, lines  2-4) . F(ab')2 fragments prepared from anti-LF-L IgG had a similar inhibitory effect on MP migration (Fig. 9, line 7) whereas neither ofthese immunologic reagents altered MP migration to FMLP (Fig. 9, lines 5 and 8, respectively) . In addition, nonimmune IgG at the same concentration had no effect on MP migration in response to AGE-albumin or FMLP added to the lower compartment of the chemotaxis chamber (Fig. 9 , lines 9 and 10, respectively). Antibody to LF-L similarly inhibited MP chemotaxis in response to AGE-albumin glycated with glucose, ribose, or to AGEs derived from diabetic patient plasma (Fig. 7 , B-D, line four in each case, respectively).
Taken together these observations are consistent with the hypothesis that access of the AGE ligand to RAGE and LF-L on the MP was required for MP migration to occur in response to soluble AGE-albumin. To explore further the nature of the ligand mediating chemotaxis, we found that preincubation of AGE-albumin, either preparations made by incubating albumin with glucose-6-phosphate, glucose, or ribose with albumin, with anti-AGE IgG blocked MP migration in a manner dependent on the antibody concentration used (Fig. 10 , A-C, respectively). Anti-AGE antibody (Fig. 10 A) and the same concentration of nonimmune IgG (designated NI, the second line in Fig. 10 , B-D) had no effect on the migration of MPs in response to FMLP. In addition, the anti-AGE antibody blocked chemotaxis in response to AGEs purified from diabetic plasma (Fig. 10 D) . This is consistent with our recent observations that the anti-AGE antibody Fig. 11 ). For these and the other studies reported below results are reported only with AGE-albumin preparations prepared with glucose-6-phosphate, since the cellular interactions of glycated albumin preparations made with glucose-6-phosphate, glucose, or ribose, as well as patient-derived AGEs, appear to be comparable. When the upper surface of the chemotaxis chamber membrane was coated with native albumin, migration in response to FMLP occurred in a dose-dependent manner, with increasing numbers of MPs appearing in the lower chamber ( Fig. 1 1, lines 1-4) . In contrast, when AGE-albumin was adsorbed to the upper surface of the chemotaxis chamber membrane, MP migration in response to FMLP was considerably reduced (Fig. 11, lines 5-7 ).
To assess ifthe inhibitory effect of immobilized AGE-albumin on MP migration to FMLP was due to interaction of the ligand with AGE-binding proteins on the MP surface, the effect of antibodies to RAGE and LF-L was studied (Fig. 12) . Preincubation of MPs with either anti-RAGE IgG (Fig. 12, line 6 ), anti-LF-L IgG (Fig. 12, line 7) , or both of these immune IgGs (Fig. 12, line 8 ) increased MP migration to the lower chamber in response to FMLP. A similar inhibitory effect was observed with F(ab')2 fragments derived from anti-RAGE IgG and anti-LF-L IgG (Fig. 12, lines 9-11) . Control experiments demonstrated that AGE-albumin, but not native albumin, had to be present on the upper surface of the chemotaxis chamber for arrest of MP migration in response to FMLP to occur (Fig. 12,  lines 1-4) . Furthermore, preincubation of MPs with nonimmune IgG (in place ofanti-AGE-binding protein IgG) did not alter MP migration (Fig. 12, line 5 ). These results predict that interference with the interaction of the immobilized glycated proteins with the AGE-binding proteins would block the effect of AGEs. Consistent with this hypothesis, addition of sRAGE to the membranes coated with AGE-albumin restored chemotaxis in response to FMLP (Fig. 13) .
These data suggested that when migrating MPs interact with immobilized AGEs their motion is slowed. Phagokinetic track assays ( 18) gration on an AGE-derivatized surface. When MPs were plated on coverslips coated with native albumin that had been overlaid with colloidal gold, long paths of migration were evident (Fig. 14 A, left) . In contrast, when AGE-albumin was used in place ofthe native molecule, the tracks were much shorter (Fig.  14 B, right) . Experiments with coverslips coated with AGEcollagen I also showed a similar reduction in the length of MP tracks compared with controls with native collagen I (data not shown).
In vivo model of AGE deposition. PTFE tubes with adsorbed AGE-albumin or native albumin provide a surface which very slowly releases the proteins over days (Fig. 15 A) . Thus, this system consists ofboth low concentrations ofsoluble Adsorbed to upper (Fig. 15 B) . In contrast, PTFE tubes with AGEs implanted for the same time incited a florid mononuclear cellular infiltrate: in Fig. 15 C, mononuclear cells are shown moving through the interstices of the PTFE mesh. Many ofthe monocytes trapped within the PTFE mesh display leukoclastic changes at higher magnification (Fig. 15 D) . After 8 d of implantation, a florid foreign body-type granulomatous response is seen primarily at the interface of PTFE tubes impregnated with native albumin (Fig. 15 E) . PTFE tubes with 1u zu 3u 4u
CELL NUMBER Ou W. Figure 13 . sRAGE restores the chemotactic response to FMLP in the presence of membranes coated with AGE albumin (prepared in the presence ofglucose-6-phosphate). sRAGE ( 100-fold molar excess over AGE coating the membrane surface) was incubated with membranes previously coated with-native albumin or AGE albumin, and then a chemotaxis assay was performed as above with FMLP as the stimulus in the lower chamber. The mean±SEM of quadruplicate determinations is shown and the experiments were repeated at least three times. adsorbed AGEs are filled with mononuclear cells (Fig. 15 F) , many of which show epithelioid changes (Fig. 15 G) .
Discussion
The results of our studies delineate a model ligand-receptor system that affects MP migration. The (Fig. 3 and Kirstein et al. [6] ), and soluble RAGE, which blocks the interaction of AGEs with cellular surfaces (32) , prevents the effects of AGEs on MP migration. Of note is that higher concentrations ofantibody were required to block the binding of '251-AGE-albumin to MPs compared with the concentrations ofantibody required to inhibit AGE-stimulated MP migration. A possible explanation for the difference in concentrations of antibodies required to alter MP migration and binding of radiolabeled AGE-albumin might be that engagement ofa limited number ofreceptors by either ofthe antibodies blocks ligand-induced activation ofa critical (i.e., threshold) number of receptors. Further studies will be required to test this hypothesis.
The ability of AGEs to modulate MP migration indicates one way in which these glycated proteins might contribute to the pathogenesis of vascular lesions: soluble AGEs loosely bound to the vessel can attract AGEs to the vessel wall and immobilized matrix-associated AGEs in the subendothelium could retain MPs and lead to their activation (6, 7) . This concept is supported by studies of Vlassara et al. (12) indicating that infusion of high concentrations of AGE-albumin leads to infiltration of the vessel wall by MPs and by our studies show
